Study guide

16.3 Endocrine Regulation, Reproductive Hormones, Calcium & Bone

APMLE Part I Basic Sciences Podiatry

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Overview & Lower Extremity Osteology

1.1 APMLE Part I Exam Structure, Policies & Scoring 1.2 Foot Osteology: Tarsals, Metatarsals, Phalanges & Sesamoids 1.3 Leg & Ankle Osteology: Tibia, Fibula & The Ankle Mortise 1.4 Pelvis, Femur & Patella Osteology: Landmarks & Biomechanics

2 Chapter 2: Lower Extremity Arthrology & Ligaments

2.1 Foot Articulations: Subtalar, Midtarsal, Lisfranc & Digital Joints 2.2 Talocrural (Ankle) & Knee Joints: Ligaments & Kinematics 2.3 Hip Joint & Pelvic Articulations: Capsular Structures & Dynamics

3 Chapter 3: Lower Extremity Myology & Compartments

3.1 Anterior & Lateral Compartments of the Leg 3.2 Superficial & Deep Posterior Compartments of the Leg 3.3 Plantar Layers & Intrinsic Musculature of the Foot 3.4 Thigh & Gluteal Musculature: Attachments & Innervations

4 Chapter 4: Lower Extremity Neurovascular & Topographical Anatomy

4.1 Lumbar & Sacral Plexuses, Peripheral Nerves & Dermatomes 4.2 Arterial Network, Venous Drainage & Lymphatics 4.3 Tarsal Tunnel, Femoral Triangle & Topographical Spaces

5 Chapter 5: Microbiology: Bacteriology, Zoonoses & Laboratory Methods

5.1 Gram-Positive Cocci & Bacilli in Podiatric Infections 5.2 Gram-Negative Bacilli & Opportunistic Pathogens 5.3 Anaerobic Pathogens & Diabetic Foot Infections 5.4 Bacterial Structure, Virulence Factors & Sterilization 5.5 Mycobacteria, Spirochetes, Mycoplasma & Zoonotic Infections 5.6 Antimicrobial Resistance, Susceptibility Testing, Specimen Handling & Vaccines

6 Chapter 6: Mycology, Virology, Parasitology & Clinical Immunology

6.1 Mycology: Dermatophytes, Onychomycosis & Systemic Mycoses 6.2 Clinically Relevant Viruses & Parasitic Infections 6.3 Innate & Adaptive Immunity Mechanisms 6.4 Hypersensitivity Reactions, Immunodeficiencies & Autoimmunity 6.5 Transplant & Tumor Immunology and Immunodiagnostic Methods

7 Chapter 7: General & Cellular Pathology

7.1 Cellular Injury, Adaptations & Cell Death Mechanisms 7.2 Acute vs Chronic Inflammation & Tissue Repair 7.3 Hemodynamic Disorders, Thrombosis, Embolism & Shock 7.4 Neoplasia, Oncogenes, Tumor Suppressors & Cutaneous Tumors

8 Chapter 8: Systemic & Podiatric Pathology

8.1 Atherosclerosis, Peripheral Artery Disease & Diabetic Microangiopathy 8.2 Osteoarthritis, Inflammatory Arthritides & Bone Infections 8.3 Neuropathic Disorders, Charcot Neuroarthropathy & Dermatopathology 8.4 Laboratory Diagnostics, Synovial Fluid & Biopsy Interpretation

9 Chapter 9: Organ-System Pathology

9.1 Anemias, Hemoglobinopathies, Leukemias & Immune Disorders 9.2 Cardiac & Pulmonary Pathology 9.3 Renal, Urogenital & Reproductive Pathology 9.4 Gastrointestinal, Hepatobiliary & Endocrine Pathology

10 Chapter 10: General Pharmacology, Autonomic Drugs & Toxicology

10.1 Pharmacokinetics, ADME & Receptor Dynamics 10.2 Cholinergic Agonists & Muscarinic/Nicotinic Antagonists 10.3 Adrenergic Agonists, Sympatholytics & Clinical Applications 10.4 Cardiovascular Pharmacology in Podiatric Patients 10.5 Drug Interactions, Adverse Effects, Pharmacogenomics & Toxicology

11 Chapter 11: Antimicrobial & Podiatric Therapeutics

11.1 Antibacterial Classes, Mechanisms & Resistances 11.2 Antifungal, Antiviral & Antiparasitic Therapeutics 11.3 NSAIDs, Opioids, Corticosteroids & Anti-Gout Agents 11.4 Local & General Anesthetic Pharmacology

12 Chapter 12: Systemic Pharmacology

12.1 Anticonvulsants, Antidepressants, Psychotropics & Skeletal Muscle Relaxants 12.2 Insulin & Noninsulin Glycemic Agents 12.3 Respiratory & Gastrointestinal Agents 12.4 DMARDs, Biologics, Antineoplastics & Immunosuppressants 12.5 Hormone Therapy, Bisphosphonates, Antihistamines, Growth Factors & Complementary Agents

13 Chapter 13: General Anatomy: Systemic Gross Anatomy & Neuroanatomy

13.1 Cranial Nerves, Head & Neck Anatomy 13.2 Thoracic Wall, Tracheobronchial Tree, Lungs & Mediastinum 13.3 Abdominal Wall, GI Viscera, Pelvis & Retroperitoneum 13.4 Vertebral Column, Spinal Cord & Upper Extremity Overview 13.5 Neuroanatomy: CNS Organization, Somatosensory & Motor Pathways

14 Chapter 14: Histology, Integument, Embryology & Genetics

14.1 Microscopic Anatomy: Epithelia, Connective Tissue, Muscle & Nerve 14.2 Integumentary System: Dermis, Appendages, Nail Unit & Cutaneous Receptors 14.3 Embryogenesis, Limb Morphogenesis & Postnatal Development 14.4 Medical Genetics & Structural Alterations in Aging

15 Chapter 15: Cellular, Neuromuscular & Cardiovascular Physiology

15.1 Membrane Potential, Ion Channels & Transport Mechanisms 15.2 Action Potentials, Synaptic Transmission & Muscle Contraction 15.3 Cardiac Electrophysiology, ECG & Hemodynamics 15.4 Blood Pressure Regulation, Poiseuille Law & Capillary Dynamics

16 Chapter 16: Organ-System Physiology: Respiratory, Renal, Endocrine, GI & Blood

16.1 Pulmonary Mechanics, Gas Exchange & Acid-Base Regulation 16.2 Renal Filtration, Tubular Transport & Fluid/Acid-Base Balance 16.3 Endocrine Regulation, Reproductive Hormones, Calcium & Bone 16.4 Gastrointestinal & Hepatobiliary Physiology 16.5 Hematology: Erythropoiesis, Leukocytes, Platelets & Coagulation 16.6 Exercise Physiology, Thermoregulation & Bone Mechanobiology

17 Chapter 17: Biochemistry: Proteins, Enzymes, Carbohydrates & Signaling

17.1 Amino Acid Chemistry, Protein Structure & Enzyme Kinetics 17.2 Glycolysis, Gluconeogenesis, Glycogen Metabolism & TCA Cycle 17.3 Electron Transport Chain, ATP Synthesis & Metabolic Inborn Errors 17.4 Hormones, Receptors, Second Messengers & Signal Transduction

18 Chapter 18: Biochemistry: Lipids, Molecular Genetics, Blood Chemistry & Nutrition

18.1 Fatty Acid Oxidation, Ketogenesis, Cholesterol & Lipoproteins 18.2 Nucleotide Metabolism, DNA Replication, Transcription, Translation & Repair 18.3 Vitamins, Micronutrients & Inborn Errors of Metabolism 18.4 Blood Chemistry: Heme Metabolism, Hemoglobin & Plasma Proteins 18.5 Nutrition: Energy Balance, Glycemic Index, Fed-Fast Cycle & Free Radicals

16.3 Endocrine Regulation, Reproductive Hormones, Calcium & Bone

Key Takeaways Explain This Topic AI

The pituitary gland originates from dual embryonic lineages: the anterior pituitary (adenohypophysis) develops from oral ectoderm (Rathke pouch) and receives hypothalamic hypophyseal portal venous regulation, while the posterior pituitary (neurohypophysis) derives from neural ectoderm and stores supraoptic-derived ADH and paraventricular-derived oxytocin within terminal Herring bodies.

Thyroid hormone biosynthesis entails basolateral NIS iodide uptake, apical pendrin transport, and Thyroid Peroxidase (TPO) organification and coupling to synthesize T4 and T3; peripheral tissue conversion of T4 to active T3 is catalyzed by 5'-deiodinase, with primary hypothyroidism (Hashimoto thyroiditis) presenting with myxedema, delayed Achilles reflex relaxation, and tarsal tunnel syndrome.

The adrenal cortex is organized into three functional zones (Glomerulosa: Aldosterone; Fasciculata: Cortisol; Reticularis: Androgens), where cortisol suppresses inflammation by inducing lipocortin-1 (annexin A1) to inhibit Phospholipase A2 and blocking NF-kB; the adrenal medulla derives from neural crest chromaffin cells and converts norepinephrine to epinephrine via PNMT, an enzyme strongly upregulated by cortical cortisol.

Pancreatic beta cells secrete equimolar insulin and C-peptide following glucose entry via GLUT2, ATP-mediated K(ATP) channel closure, and calcium-dependent exocytosis; insulin binds receptor tyrosine kinases to mobilize GLUT4 in skeletal muscle and adipose tissue, while stimulating cellular potassium uptake.

Extracellular calcium and phosphate homeostasis is coordinated by Parathyroid Hormone (PTH), active Vitamin D (calcitriol), and calcitonin: PTH acts via osteoblast RANKL to induce osteoclast bone resorption, stimulates distal tubular Ca2+ reabsorption, promotes proximal tubular phosphaturia, and upregulates 1-alpha-hydroxylase; primary hyperparathyroidism produces hypercalcemia and hypophosphatemia, while Vitamin D deficiency manifests as rickets in children and osteomalacia with Looser zones in adults.

Last updated: October 2026

16.3 Endocrine Regulation, Reproductive Hormones, Calcium & Bone

Independent Study Guide Notice: Independent study guide by ExamFinch. This educational resource is developed independently by ExamFinch and is not sponsored, endorsed, or affiliated with the National Board of Podiatric Medical Examiners (NBPME) or Meazure Learning.

Hypothalamic-Pituitary Axis: Embryology & Architecture

The pituitary gland (hypophysis cerebri) sits within the sella turcica of the sphenoid bone, immediately inferior to the optic chiasm. It comprises two developmentally, morphologically, and functionally distinct divisions: Embryological Duality of the Pituitary Gland

  • ORAL CAVITY ROOF (Stomodeum) FLOOR OF DIENCEPHALON
  • [Oral Ectoderm] [Neuroectoderm]
  • │ │
  • ▼ Upgrowth ▼ Downgrowth
  • Rathke Pouch Infundibulum
  • │ │
  • ▼ ▼
  • ANTERIOR PITUITARY POSTERIOR PITUITARY
  • (Adenohypophysis) (Neurohypophysis)
  • Glandular Epithelial Cells - Axons from Supraoptic (ADH) &
  • Hypophyseal Portal Venous System Paraventricular (Oxytocin) Nuclei
  • Hormones: TSH, ACTH, FSH, - Stored in HERRING BODIES
  • LH, GH, Prolactin - Supported by PITUICYTES
  • 1. Anterior Pituitary (Adenohypophysis)

Embryological Derivation: Arises from an upward invagination of oral ectoderm from the roof of the primitive stomodeum termed Rathke's pouch . A persistent vestige of Rathke's pouch can give rise to a craniopharyngioma (a benign suprasellar tumor in children presenting with bitemporal hemianopsia and calcifications on imaging).

Vascular Control: Regulated by hypothalamic releasing and inhibiting hormones transported through the hypophyseal portal venous system (capillary plexus of the median eminence → \rightarrow → portal venules → \rightarrow → secondary capillary plexus of adenohypophysis).

Secretory Cell Lineages & Hormones:

Corticotropes: Synthesize Adrenocorticotropic Hormone (ACTH) , cleaved from the massive precursor polypeptide Pro-opiomelanocortin (POMC) along with β \beta β -endorphin and Melanocyte-Stimulating Hormone ( α \alpha α -MSH) .

Thyrotropes: Synthesize Thyroid-Stimulating Hormone (TSH) . Composed of a common glycoprotein α \alpha α -subunit (shared identically with LH, FSH, and hCG) and a unique β \beta β -subunit that confers receptor specificity.

Gonadotropes: Synthesize Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) .

Somatotrope Cells: Synthesize Growth Hormone (GH / Somatotropin) . Acts via a transmembrane JAK-STAT receptor tyrosine kinase to stimulate hepatic synthesis and secretion of Insulin-Like Growth Factor 1 (IGF-1 / Somatomedin C) , which drives epiphyseal chondrocyte proliferation and longitudinal bone growth.

Lactotropes: Synthesize Prolactin . Uniquely under tonic hypothalamic inhibition by Dopamine acting via pituitary D 2 D_2 D 2 ​ receptors. Antipsychotics (dopamine receptor antagonists) block this inhibition, causing hyperprolactinemia, galactorrhea, and amenorrhea.

2. Posterior Pituitary (Neurohypophysis)

Embryological Derivation: Arises from a downward evagination of neuroectoderm from the ventral diencephalon (hypothalamus), remaining physically connected to the brain via the infundibular stalk.

Cellular Morphology: Does not synthesize hormones; instead, it consists of unmyelinated nerve terminal axons and supporting specialized glial cells termed pituicytes .

Hormone Storage & Release:

Antidiuretic Hormone (ADH / Vasopressin): Synthesized in cell bodies of the hypothalamic supraoptic nucleus .

Oxytocin: Synthesized in cell bodies of the hypothalamic paraventricular nucleus .

Both peptide hormones are packaged into neurosecretory granules bound to carrier proteins termed neurophysins , transported down the hypothalamo-hypophyseal tract via fast axonal transport, and stored in dilated terminal axon dilations known as Herring bodies in the posterior lobe prior to exocytosis.

Thyroid Physiology & Clinical Pathology Thyroid Hormone Biosynthesis in Follicular Cell

  • BASOLATERAL (Blood) FOLLICULAR CELL APICAL (Colloid Lumen)
  • ─────────────────── ─────────────── ──────────────────────
  • 2 Na+ ══► [NIS] ══► I- ──────────────────────────────► [Pendrin] ══► I-
  • (Sodium-Iodide Symporter) │
  • ▼
  • THYROID PEROXIDASE
  • (TPO) [Oxidation]
  • │
  • ▼
  • I° or I+ (Active Iodine)
  • │
  • + Thyroglobulin (Tg)
  • ▼
  • ORGANIFICATION
  • MIT and DIT formed
  • │
  • TPO COUPLING
  • MIT + DIT = T3
  • DIT + DIT = T4
  • │
  • CIRCULATION ◄═════════════ LYSOSOMAL PROTEOLYSIS ◄═════ ENDOCYTOSIS
  • T4 (prohormone, 90%) cleaves Tg to release T4/T3 of colloid droplets
  • T3 (active form, 10%)
  • │
  • ▼ [5'-Deiodinase in liver/kidneys]
  • ACTIVE T3 (Binds Nuclear Thyroid Receptor)
  • Biosynthetic Steps of Thyroid Hormones

Iodide Trapping: Dietary iodide ( I − I^- I − ) is actively cotransported across the basolateral follicular membrane via the N a + / I − Na^+/I^- N a + / I − Symporter (NIS) , utilizing the steep chemical gradient generated by the N a + / K + Na^+/K^+ N a + / K + ATPase. (Competitively inhibited by anions: perchlorate, pertechnetate, thiocyanate).

Apical Iodide Efflux: Iodide is transported across the apical membrane into the follicular colloid lumen via pendrin ( I − / C l − I^-/Cl^- I − / C l − exchanger).

Oxidation & Organification: Thyroid Peroxidase (TPO) , a heme enzyme situated on the apical membrane, oxidizes iodide ( I − I^- I − ) into reactive neutral iodine ( I 0 I^0 I 0 ). TPO then immediately organifies the iodine by iodinating tyrosine residues within thyroglobulin (Tg) , forming Monoiodotyrosine (MIT) and Diiodotyrosine (DIT) .

Coupling: TPO catalyzes the covalent coupling of iodotyrosine residues on the thyroglobulin scaffold: MIT + DIT ⟶ Triiodothyronine (T3) \text{MIT} + \text{DIT} \longrightarrow \text{Triiodothyronine (T3)} MIT + DIT ⟶ Triiodothyronine (T3) DIT + DIT ⟶ Thyroxine (T4) \text{DIT} + \text{DIT} \longrightarrow \text{Thyroxine (T4)} DIT + DIT ⟶ Thyroxine (T4)

Pharmacologic Inhibition: Thionamides ( Propylthiouracil [PTU] and Methimazole ) inhibit TPO, blocking both organification and coupling.

Colloid Endocytosis & Secretion: Under TSH stimulation, pseudopodia endocytose colloid droplets. Lysosomes fuse with droplets, and acid proteases cleave T3 and T4 from thyroglobulin, releasing free hormones into the circulation in a ~20:1 ratio (T4 > T3).

Peripheral Conversion (5'-Deiodinase): T4 is a prohormone. In peripheral tissues (liver, kidneys, skeletal muscle), the outer ring iodine is removed by 5'-deiodinase to generate biologically active T3 (which has 4-5 times higher affinity for the nuclear thyroid hormone receptor than T4). 5'-deiodinase is inhibited by Propylthiouracil (PTU), β \beta β -blockers (propranolol), systemic corticosteroids, and amiodarone .

Physiological Actions of Thyroid Hormones (T3)

Basal Metabolic Rate (BMR): Increases transcription and membrane expression of N a + / K + Na^+/K^+ N a + / K + ATPase pumps , accelerating cellular oxygen consumption, ATP turnover, and caloric heat production ( calorigenic effect ).

Cardiovascular Dynamics: Upregulates myocardial β 1 \beta_1 β 1 ​ -adrenergic receptors and sarcoplasmic reticulum C a 2 + Ca^{2+} C a 2 + -ATPase (SERCA), increasing resting heart rate, stroke volume, myocardial contractility, and cardiac output.

Neurodevelopment & Bone: Essential for fetal brain development, myelinogenesis, and synaptogenesis; deficiency in early infancy causes irreversible intellectual disability and short stature ( congenital hypothyroidism / cretinism ). Accelerates chondrocyte maturation in epiphyseal growth plates.

Clinical Thyroid Pathologies: Podiatric Correlations

Hashimoto Thyroiditis (Chronic Autoimmune Thyroiditis):

Most common cause of primary hypothyroidism in the United States.

Autoantibodies against Thyroid Peroxidase (anti-TPO) and Thyroglobulin (anti-Tg) destroy thyroid follicles. Histology reveals dense lymphocytic infiltration with well-developed germinal centers and metaplastic eosinophilic follicular cells ( Hürthle cells / Askanazy cells ).

Clinical Manifestations: Cold intolerance, weight gain, constipation, coarse dry skin, and delayed relaxation phase of deep tendon reflexes ("hung-up" Achilles reflex / Woltman sign) .

Podiatric Correlation: Widespread deposition of hydrophilic glycosaminoglycans (hyaluronic acid) within interstitial connective tissues causes non-pitting myxedema . Swelling within fibro-osseous tunnels precipitates peripheral nerve entrapment neuropathies, specifically Carpal Tunnel Syndrome (median nerve) and Tarsal Tunnel Syndrome (posterior tibial nerve entrapment beneath the flexor retinaculum posterior to the medial malleolus).

Graves Disease:

Most common cause of hyperthyroidism. Autoantibodies ( Thyroid-Stimulating Immunoglobulins [TSI] / TRAb ) bind and constitutively activate the follicular TSH receptor , driving autonomous hormone synthesis and diffuse goiter.

Pathognomonic Manifestations:

Graves Ophthalmopathy (Proptosis): Orbital fibroblasts express TSH receptors; autoantibody stimulation triggers cytokine release, hyaluronic acid accumulation, and profound retro-orbital edema, pushing the globe forward.

Pretibial Myxedema (Thyroid Dermopathy): Non-pitting, indurated, violaceous, "orange-peel" (peau d'orange) plaques localized over the anterior pretibial surface of the lower leg and dorsal foot .

Adrenal Gland & Endocrine Pancreas Adrenal Gland Zonation & Steroidogenesis

  • LAYER REGULATOR PRIMARY HORMONE FUNCTION (Mnemonic)
  • ───────────────────────────────────────────────────────────────────────────────

CORTEX (Mesoderm):

  • 1. Zona Glomerulosa (15%) Angiotensin II ALDOSTERONE Salt (Na+ retain, K+ dump)
  • 2. Zona Fasciculata (75%) ACTH CORTISOL Sugar (Gluconeogenesis, Anti-inflammatory)
  • 3. Zona Reticularis (10%) ACTH DHEA / Androgens Sex (Secondary sexual traits)
  • ───────────────────────────────────────────────────────────────────────────────
  • MEDULLA (Neural Crest): Sympathetic EPINEPHRINE (80%) Fight or Flight
  • Chromaffin Cells Pre-ganglionic NOREPINEPHRINE (Vasoconstriction,
  • (ACh) (20%) Bronchodilation)
  • Adrenal Cortical Zonation: Salt, Sugar, Sex

Zona Glomerulosa (Mineralocorticoids): Regulated predominantly by the Renin-Angiotensin-Aldosterone System (RAAS) and extracellular [ K + ] [K^+] [ K + ] . Secretes Aldosterone (via aldosterone synthase). Acts on the distal nephron to promote sodium/water retention and potassium/proton secretion.

Zona Fasciculata (Glucocorticoids): Regulated by hypothalamic CRH → \rightarrow → pituitary ACTH . Secretes Cortisol .

Metabolic Actions: Stimulates hepatic gluconeogenesis and glycogenolysis; accelerates peripheral skeletal muscle proteolysis and adipose lipolysis (supplying amino acids and glycerol substrates); downregulates GLUT4 translocation, causing peripheral insulin resistance.

Anti-Inflammatory & Immunosuppressive Actions:

Induces the transcription of Lipocortin-1 (Annexin A1) , which directly binds and inhibits Phospholipase A2 ( P L A 2 PLA_2 P L A 2 ​ ) . This halts the liberation of arachidonic acid from cell membrane phospholipids, shutting down the downstream synthesis of both prostaglandins/thromboxane (COX pathway) and leukotrienes (5-LOX pathway) .

Inhibits Nuclear Factor κ \kappa κ B (NF- κ \kappa κ B) , blocking the transcription of pro-inflammatory cytokines: IL-1, IL-2, IL-6, and TNF- α \alpha α .

Inhibits leukocyte rolling and extravasation (causes peripheral leukocytosis due to demargination of neutrophils), while inducing apoptosis of T-lymphocytes and eosinophils.

Bone & Connective Tissue Actions: Inhibits osteoblast proliferation and matrix synthesis; decreases intestinal C a 2 + Ca^{2+} C a 2 + absorption; accelerates osteoclast bone resorption. Chronic glucocorticoid excess triggers rapid osteoporosis and avascular necrosis (osteonecrosis) of the femoral and talar heads .

Zona Reticularis (Androgens): Regulated by ACTH. Secretes Dehydroepiandrosterone (DHEA) and androstenedione.

Adrenal Medulla: Neural Crest Catecholamines

Chromaffin Cells: Modified postganglionic neuroendocrine cells derived embryologically from the neural crest . Innervated directly by preganglionic sympathetic fibers that release Acetylcholine (ACh) onto nicotinic ( N N N_N N N ​ ) receptors.

Catecholamine Synthesis: Tyrosine → Tyrosine Hydroxylase L-DOPA → DOPA Decarboxylase Dopamine → Dopamine β -Hydroxylase Norepinephrine → PNMT Epinephrine \text{Tyrosine} \xrightarrow{\text{Tyrosine Hydroxylase}} \text{L-DOPA} \xrightarrow{\text{DOPA Decarboxylase}} \text{Dopamine} \xrightarrow{\text{Dopamine } \beta\text{-Hydroxylase}} \text{Norepinephrine} \xrightarrow{\text{PNMT}} \text{Epinephrine} Tyrosine Tyrosine Hydroxylase ​ L-DOPA DOPA Decarboxylase ​ Dopamine Dopamine β -Hydroxylase ​ Norepinephrine PNMT ​ Epinephrine

PNMT Upregulation: The terminal conversion of norepinephrine to epinephrine is catalyzed by Phenylethanolamine N-methyltransferase (PNMT) . PNMT is uniquely induced and maintained by high concentrations of cortisol draining directly from the adrenal cortex through intra-adrenal portal sinusoids!

Adrenocortical Pathologies

Cushing Syndrome (Hypercortisolism): Central obesity, buffalo hump, moon facies, violaceous abdominal striae, muscle atrophy, osteoporosis, impaired wound healing, hyperglycemia. Most common cause overall is exogenous corticosteroid administration . Cushing Disease refers specifically to an ACTH-secreting anterior pituitary adenoma.

Primary Adrenal Insufficiency (Addison Disease): Autoimmune destruction of all three adrenal cortical layers. Causes combined deficiency of aldosterone (hypotension, hyponatremia, hyperkalemia, non-anion gap metabolic acidosis) and cortisol (hypoglycemia, fatigue). Loss of cortisol negative feedback induces massive transcription of pro-opiomelanocortin (POMC), generating excess ACTH and α \alpha α -MSH, which bind MC1R on melanocytes to produce pathognomonic cutaneous and mucosal hyperpigmentation (buccal mucosa, skin creases, scar lines).

Endocrine Pancreas: Insulin Kinetics & Action

Islets of Langerhans: Composed of central β \beta β -cells (65-75%; Insulin, Amylin), peripheral α \alpha α -cells (15-20%; Glucagon), and interspersed δ \delta δ -cells (3-10%; Somatostatin).

Insulin Synthesis & C-Peptide: Preproinsulin is synthesized in the rough ER, where the signal sequence is cleaved to form proinsulin . In Golgi secretory granules, proinsulin is cleaved by endopeptidases into mature Insulin (51 amino acids across A and B chains linked by disulfide bonds) and equimolar C-Peptide (Connecting Peptide) .

Clinical Utility of C-Peptide: Because commercial pharmaceutical insulin preparations contain no C-peptide, measuring serum C-peptide allows clinicians to differentiate endogenous insulin hypersecretion (insulinoma, sulfonylurea use; C-peptide elevated) from surreptitious factitious exogenous insulin injection (C-peptide low or undetectable with high insulin).

B-Cell Secretion Mechanism: Glucose enters β \beta β -cells via insulin-independent GLUT2 transporters → \rightarrow → phosphorylated by glucokinase → \rightarrow → glycolysis and Krebs cycle elevate intracellular [ A T P ] / [ A D P ] [ATP]/[ADP] [ A TP ] / [ A D P ] ratio → \rightarrow → closes ATP-sensitive K + K^+ K + channels ( K A T P K_{ATP} K A TP ​ ) → \rightarrow → cell membrane depolarizes → \rightarrow → opens voltage-gated C a 2 + Ca^{2+} C a 2 + channels → C a 2 + \rightarrow Ca^{2+} → C a 2 + influx triggers insulin exocytosis .

Sulfonylureas (glipizide, glyburide) and Meglitinides bind directly to the SUR1 subunit of the K A T P K_{ATP} K A TP ​ channel, closing it mechanically to stimulate insulin secretion.

Insulin Signaling Cascade: Insulin binds its transmembrane Receptor Tyrosine Kinase (RTK) → \rightarrow → autophosphorylation of intracellular β \beta β -subunits → \rightarrow → recruitment and phosphorylation of Insulin Receptor Substrates (IRS-1, IRS-2) → \rightarrow → activation of the PI3K / Akt (Protein Kinase B) pathway → \rightarrow → stimulates exocytic translocation of GLUT4 glucose transporters to the plasma membrane in skeletal muscle and adipose tissue .

Net Actions: Anabolic: drives glycogenesis, lipogenesis, protein translation; strongly stimulates cellular potassium uptake by activating the N a + / K + Na^+/K^+ N a + / K + ATPase.

Calcium & Bone Homeostasis

Extracellular calcium ( [ C a 2 + ] ≈ 8.5 – 10.5 mg/dL [Ca^{2+}] \approx 8.5\text{--}10.5 \text{ mg/dL} [ C a 2 + ] ≈ 8.5 – 10.5 mg/dL , ionized fraction ∼ 4.5 – 5.5 mg/dL \sim 4.5\text{--}5.5 \text{ mg/dL} ∼ 4.5 – 5.5 mg/dL ) and phosphate ( [ H P O 4 2 − ] ≈ 3.0 – 4.5 mg/dL [HPO_4^{2-}] \approx 3.0\text{--}4.5 \text{ mg/dL} [ H P O 4 2 − ​ ] ≈ 3.0 – 4.5 mg/dL ) are tightly coordinated by three primary hormones: Parathyroid Hormone (PTH) , Active Vitamin D ( 1 , 25 -(OH) 2 -D 3 1,25\text{-(OH)}_2\text{-D}_3 1 , 25 -(OH) 2 ​ -D 3 ​ / Calcitriol) , and Calcitonin : Systemic Calcium & Phosphate Homeostasis

  • LOW SERUM IONIZED Ca2+
  • │
  • ▼ Derepresses CaSR
  • PARATHYROID GLANDS
  • (Chief Cells secrete PTH)
  • │
  • ┌────────────────────────────┼────────────────────────────┐
  • ▼ ▼ ▼
  • BONE KIDNEY KIDNEY
  • Binds Osteoblasts DCT: Stimulates PCT: Inhibits NaPi-IIa
  • > Upregulates RANKL TRPV5 channels cotransporters
  • > Activates Osteoclasts -> Reabsorbs Ca2+ -> PHOSPHATURIA
  • > Resorbs Ca2+ & PO43- │ (Prevents Ca-PO4 stones)
  • │ │ │
  • │ ▼ │
  • │ Upregulates Renal │
  • │ 1α-Hydroxylase │
  • │ (Converts 25-OH-D3 │
  • │ to 1,25-(OH)2-D3) │
  • │ │ │
  • │ ▼ │
  • │ SMALL INTESTINE │
  • │ Stimulates Calbindin │
  • │ & TRPV6 transporters │
  • │ -> Absorbs Ca2+ & PO43- │
  • ▼ │ ▼
  • ELEVATES SERUM Ca2+ ◄───────────────┴──────────────────► LOWERS SERUM PO43-
  • 1. Parathyroid Hormone (PTH)

Synthesis & Regulation: Secreted by chief cells of the four parathyroid glands. Chief cells express cell-surface Calcium-Sensing Receptors (CaSR) , which are G-protein coupled ( G q G_q G q ​ and G i G_i G i ​ ). High ionized serum [ C a 2 + ] [Ca^{2+}] [ C a 2 + ] binds CaSR, activating intracellular pathways that inhibit PTH gene transcription and exocytosis . Conversely, a decrease in ionized calcium derepresses CaSR, triggering rapid PTH release within seconds.

Actions on Bone (Indirect Osteoclast Activation):

Mature osteoclasts do not possess functional PTH receptors!

PTH binds G-protein coupled receptors ( G s → c A M P G_s \rightarrow cAMP G s ​ → c A MP ) on osteoblasts .

Osteoblasts respond by upregulating surface expression of RANKL (Receptor Activator of Nuclear Factor κ \kappa κ B Ligand) and downregulating secretion of Osteoprotegerin (OPG) , a soluble decoy receptor for RANKL.

RANKL binds the RANK receptor on osteoclast precursor cells of the monocyte/macrophage lineage, driving their fusion, differentiation, and activation into mature multinucleated osteoclasts.

Osteoclasts dissolve hydroxyapatite crystals, mobilizing both Calcium and Phosphate into the circulation.

Actions on the Kidney:

Distal Convoluted Tubule: Directly stimulates active transcellular reabsorption of C a 2 + Ca^{2+} C a 2 + via apical TRPV5 channels and basolateral NCX1 extrusion.

Proximal Convoluted Tubule (Phosphaturia): Inhibits apical sodium-phosphate cotransporters ( NaPi-IIa ), causing rapid endocytosis and lysosomal degradation of the transporter. This prevents phosphate reabsorption, producing profound phosphaturia . Biochemical Rationale: Because bone resorption releases both calcium and phosphate, phosphate must be eliminated in urine to prevent the calcium-phosphate solubility product ( [ C a 2 + ] × [ P O 4 3 − ] [Ca^{2+}] \times [PO_4^{3-}] [ C a 2 + ] × [ P O 4 3 − ​ ] ) from exceeding critical crystallization thresholds that trigger soft-tissue and vascular calcification!

Stimulation of 1 α 1\alpha 1 α -Hydroxylase: Upregulates transcription of the renal mitochondrial enzyme 1 α 1\alpha 1 α -hydroxylase (CYP27B1) in the PCT, converting inactive calcidiol into active calcitriol.

Net Serum Effects of PTH: ↑ \uparrow ↑ Serum Calcium, ↓ \downarrow ↓ Serum Phosphate, ↑ \uparrow ↑ Urinary cAMP .

2. Active Vitamin D ( 1 , 25 -(OH) 2 -D 3 1,25\text{-(OH)}_2\text{-D}_3 1 , 25 -(OH) 2 ​ -D 3 ​ / Calcitriol)

Metabolic Pathway: 7-Dehydrocholesterol (Skin) → UVB Light Cholecalciferol (Vit D 3 ) → Liver: 25-Hydroxylase 25 -(OH)-D 3 (Calcidiol) \text{7-Dehydrocholesterol (Skin)} \xrightarrow{\text{UVB Light}} \text{Cholecalciferol (Vit } D_3) \xrightarrow{\text{Liver: 25-Hydroxylase}} 25\text{-(OH)-D}_3 \text{ (Calcidiol)} 7-Dehydrocholesterol (Skin) UVB Light ​ Cholecalciferol (Vit D 3 ​ ) Liver: 25-Hydroxylase ​ 25 -(OH)-D 3 ​ (Calcidiol) 25 -(OH)-D 3 → Kidney PCT: 1 α -Hydroxylase (Stimulated by PTH) 1 , 25 -(OH) 2 -D 3 (Calcitriol) 25\text{-(OH)-D}_3 \xrightarrow{\text{Kidney PCT: 1}\alpha\text{-Hydroxylase (Stimulated by PTH)}} 1,25\text{-(OH)}_2\text{-D}_3 \text{ (Calcitriol)} 25 -(OH)-D 3 ​ Kidney PCT: 1 α -Hydroxylase (Stimulated by PTH) ​ 1 , 25 -(OH) 2 ​ -D 3 ​ (Calcitriol)

Primary Intestinal Actions: Calcitriol binds nuclear Vitamin D Receptors (VDR) in duodenal and jejunal enterocytes, acting as a steroid hormone transcription factor to upregulate:

Apical calcium channels ( TRPV6 ).

Intracellular calcium transport chaperone protein ( Calbindin-D28k ).

Basolateral C a 2 + Ca^{2+} C a 2 + -ATPase (PMCA1b) and sodium-phosphate cotransporters.

Net Serum Effects of Calcitriol: ↑ \uparrow ↑ Serum Calcium AND ↑ \uparrow ↑ Serum Phosphate (promotes systemic bone mineralization).

3. Calcitonin

Secreted by parafollicular C cells of the thyroid gland (derived from neural crest / ultimopharyngeal body) in response to hypercalcemia.

Directly binds receptors on mature osteoclasts , instantly inactivating their ruffled border and halting bone resorption. (Serves as a tumor marker for medullary thyroid carcinoma).

Hormone Primary Source Major Bone Action Major Renal Action Major Intestinal Action Net Serum [ C a 2 + ] [Ca^{2+}] [ C a 2 + ] Net Serum [ P O 4 3 − ] [PO_4^{3-}] [ P O 4 3 − ​ ]

PTH Parathyroid Chief Cells Stimulates osteoblast RANKL → \rightarrow → osteoclast resorption ↑ C a 2 + \uparrow Ca^{2+} ↑ C a 2 + reabsorption (DCT); ↓ P O 4 3 − \downarrow PO_4^{3-} ↓ P O 4 3 − ​ reabsorption (PCT); ↑ 1 α \uparrow 1\alpha ↑ 1 α -hydroxylase Indirect via calcitriol Increased ( ↑ \uparrow ↑ ) Decreased ( ↓ \downarrow ↓ )

Calcitriol ( 1 , 25 -(OH) 2 -D 3 1,25\text{-(OH)}_2\text{-D}_3 1 , 25 -(OH) 2 ​ -D 3 ​ ) Kidney PCT ( 1 α 1\alpha 1 α -hydroxylase) Facilitates mineralization at physiological doses; resorptive at toxic levels Stimulates mild C a 2 + Ca^{2+} C a 2 + and P O 4 3 − PO_4^{3-} P O 4 3 − ​ reabsorption Markedly ↑ C a 2 + \uparrow Ca^{2+} ↑ C a 2 + (calbindin) and ↑ P O 4 3 − \uparrow PO_4^{3-} ↑ P O 4 3 − ​ absorption Increased ( ↑ \uparrow ↑ ) Increased ( ↑ \uparrow ↑ )

Calcitonin Thyroid Parafollicular C Cells Directly inhibits osteoclast resorption Mildly ↑ C a 2 + \uparrow Ca^{2+} ↑ C a 2 + excretion None Decreased ( ↓ \downarrow ↓ ) Decreased ( ↓ \downarrow ↓ )

FGF23 Osteocytes / Osteoblasts Suppresses bone mineralization Inhibits PCT P O 4 3 − PO_4^{3-} P O 4 3 − ​ reabsorption (Phosphaturia) ; inhibits 1 α 1\alpha 1 α -hydroxylase None Unchanged Decreased ( ↓ \downarrow ↓ )

Clinical Calcium & Osseous Pathologies

Primary Hyperparathyroidism: Most commonly caused by a solitary benign parathyroid adenoma (~85%). Hypersecretion of PTH despite elevated calcium.

Laboratory Profile: Elevated serum [ C a 2 + ] [Ca^{2+}] [ C a 2 + ] , decreased serum [ P O 4 3 − ] [PO_4^{3-}] [ P O 4 3 − ​ ] , elevated intact PTH, elevated urinary cAMP, and elevated 24-hour urinary calcium (high filtered load overwhelms tubular reabsorption).

Clinical Presentation ("Stones, Bones, Groans, and Psychiatric Overtones"): Calcium oxalate nephrolithiasis, osteitis fibrosa cystica (subperiosteal cortical resorption, "salt-and-pepper" skull, brown tumors of fibrous tissue and osteoclasts), constipation, peptic ulcer disease (calcium stimulates gastrin), and neuropsychiatric depression.

Secondary Hyperparathyroidism: Arises from Chronic Kidney Disease (CKD) . Failing kidneys cannot excrete phosphate (causing hyperphosphatemia) and lose functional renal parenchyma containing 1 α 1\alpha 1 α -hydroxylase (causing calcitriol deficiency). Resulting hypocalcemia drives chronic, massive compensatory hyperplasia of all four parathyroid glands.

Laboratory Profile: High PTH, Low or Normal [ C a 2 + ] [Ca^{2+}] [ C a 2 + ] , High [ P O 4 3 − ] [PO_4^{3-}] [ P O 4 3 − ​ ] , low calcitriol. Leads to renal osteodystrophy .

Hypoparathyroidism: Arises most frequently from accidental surgical excision of parathyroid glands during total thyroidectomy, or autoimmune polyglandular syndrome 1.

Laboratory Profile: Low serum [ C a 2 + ] [Ca^{2+}] [ C a 2 + ] , elevated serum [ P O 4 3 − ] [PO_4^{3-}] [ P O 4 3 − ​ ] , low PTH.

Clinical Presentation (Hypocalcemic Tetany): Neuromuscular hyper-excitability, perioral paresthesias, carpopedal spasm, Chvostek sign (ipsilateral facial twitching upon tapping the facial nerve anterior to the ear), Trousseau sign (painful carpal spasm elicited by inflating a sphygmomanometer cuff above systolic pressure for 3 minutes), and prolonged QT interval on electrocardiogram (predisposing to torsades de pointes).

Vitamin D Deficiency: Rickets & Osteomalacia:

Defective mineralization of uncalcified osteoid matrix due to low calcium-phosphate product.

Rickets (Pediatric): Affects open epiphyseal growth plates. Chondrocytes in the zone of hypertrophy fail to calcify; unmineralized osteoid accumulates, causing wide, cupped, frayed metaphyses, rachitic rosary of costochondral junctions, craniotabes, and severe weight-bearing bowing deformities of the lower extremities ( genu varum or genu valgum ).

Osteomalacia (Adult): Affects remodeling bone after epiphyseal plate closure. Presents with diffuse bone pain, muscle weakness, and pathognomonic radiolucent cortical fracture lines perpendicular to the long axis of bone ( Looser zones / pseudofractures / Milkman lines ), frequently observed in the metatarsal shafts, femoral neck, and pelvis.

Laboratory Profile: Low 25 -(OH)-D 25\text{-(OH)-D} 25 -(OH)-D , low-normal [ C a 2 + ] [Ca^{2+}] [ C a 2 + ] , low [ P O 4 3 − ] [PO_4^{3-}] [ P O 4 3 − ​ ] , compensatory elevated PTH , and markedly elevated Alkaline Phosphatase (ALP) .

Reproductive Endocrinology

The outline's endocrine heading covers the gonadal axis as well as the pituitary, thyroid, adrenal, pancreatic and calcium hormones.

Hypothalamic-pituitary-gonadal axis: pulsatile GnRH stimulates anterior pituitary LH and FSH , which act through Gs and cAMP. Continuous GnRH-agonist exposure (leuprolide) downregulates the axis, which is used in prostate cancer and endometriosis.

Testis:

LH stimulates Leydig cells to make testosterone from cholesterol.

FSH stimulates Sertoli cells to support spermatogenesis and to secrete inhibin B , which feeds back on FSH, and androgen-binding protein.

Testosterone is converted to dihydrotestosterone by 5-alpha-reductase (blocked by finasteride) and to estradiol by aromatase.

Ovary:

In the follicular phase, FSH-driven granulosa cells use aromatase to convert theca-cell androgens into estradiol (the two-cell model).

Rising estradiol switches to positive feedback , causing the mid-cycle LH surge and ovulation.

The corpus luteum then secretes progesterone .

Estrogen and bone: estrogen limits osteoclast activity, partly by raising osteoprotegerin and lowering RANKL. The fall in estrogen at menopause accelerates bone loss, which explains postmenopausal osteoporosis and fragility fractures, including metatarsal stress fractures. Estrogen also drives epiphyseal closure in both sexes, so aromatase or estrogen-receptor deficiency causes tall stature with open growth plates.

Hormone-binding proteins: sex hormone-binding globulin and albumin carry testosterone and estradiol. Only the free fraction is active (17.4).

Pregnancy: human chorionic gonadotropin maintains the corpus luteum until the placenta takes over progesterone production. Relaxin and estrogen increase ligamentous laxity. Pregnancy also brings edema, weight gain and arch flattening, and it raises the risk of venous thromboembolism.